Low-dose solumatrix meloxicam demonstrates low systemic exposure and efficacy in patients with osteoarthitis pain in clinical studies

Authors
Category Primary study
JournalOsteoarthritis and Cartilage
Year 2015
This article has no abstract
Epistemonikos ID: 6bff85be60f741217ab2d0e0dc15d271b9e1face
First added on: Feb 07, 2025